Loading grant details…
NIAID- VRC- Research, Development, and Production to Support Clinical Trials for HIV Vaccines.
| Funder | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES |
|---|---|
| Recipient Organization | Leidos Biomedical Research, Inc. |
| Country | United States |
| Start Date | Apr 12, 2022 |
| End Date | Jul 17, 2027 |
| Duration | 1,922 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10722425 |
Grant Description
The Dale and Betty Bumpers Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), at the National Institutes of Health, was established to facilitate research in vaccine development and is dedicated to improving global human health through the rigorous pursuit of effective vaccines and treatments for human diseases.
One of the key components of the VRC's mission involves the rapid advancement of promising candidates from the laboratory to the clinic.
Meeting this mission necessitates the development and manufacturing of vaccines for toxicology, and Phase 1/11 clinical trials.
All Grantees
Leidos Biomedical Research, Inc.
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Related Grants
